NCT00005021View on ClinicalTrials.gov

Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or Lymphoma

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

July 31, 1996

Primary Completion Date

May 31, 2003

Study Completion Date

May 31, 2003

Conditions
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

filgrastim

DRUG

carboplatin

DRUG

paclitaxel

DRUG

topotecan hydrochloride

Trial Locations (1)

19111

Fox Chase Cancer Center, Philadelphia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fox Chase Cancer Center

OTHER

NCT00005021 - Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or Lymphoma | Biotech Hunter | Biotech Hunter